eli lily tirzepatide FDA approval for Zepbound (tirzepatide) injection, the first and only obesity treatment of its kind that activates both GIP and GLP-1 hormone receptors - Lilly Why Eli Lilly Stock Jumped

For some patients, particularly those managing type 2 diabetes or severe obesity with related health risks, the conversation with their doctor may absolutely lead here

Studies have shown a link between these benefits and improvements in things like blood pressure, cholesterol levels, and overall blood vessel health, she says

Promising efficacy so far: Mid-stage trials show large average weight reductions and metabolic improvements, but phase 3 data are still pending

This is why you might find hairs on your hairbrush or in the sink or the shower

Why managing GLP-1 side effects is critical for adherence As GLP-1 medications become more widely used, adherence challenges are becoming more visible in real-world settings